CoChat

A WHO Reference Reagent for lupus (anti-dsDNA) antibodies: international collaborative study to evaluate a candidate preparation

Open access

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Antibodies against double-stranded DNA (anti-dsDNA) are a specific biomarker for systemic lupus erythematosus (SLE). The first WHO International Standard (IS) for anti-dsDNA (established in 1985), which was used to assign units to diagnostic tests, was exhausted over a decade ago. METHODS: Plasma from a patient with SLE was first evaluated in 42 European laboratories. The plasma was thereafter used by the National Institute for Biological Standards and Control to prepare a candidate WHO reference preparation for lupus (anti-dsDNA) antibodies. That preparation, coded 15/174, was subjected to an international collaborative study, including 36 laboratories from 17 countries. RESULTS: The plasma mainly contained anti-dsDNA, other anti-chromatin antibodies and anti-Ku. The international collaborative study showed that the field would benefit from 15/174 as a common reference reagent improving differences in performance between different assays. However, no statistically meaningful overall potency or assay parallelism and commutability could be shown. CONCLUSION: 15/174 cannot be considered equivalent to the first IS for anti-dsDNA (Wo/80) and was established as a WHO Reference Reagent for lupus (oligo-specific) anti-dsDNA antibodies with a nominal value of 100 units/ampoule. This preparation is intended to be used to align test methods quantifying levels of anti-dsDNA antibodies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/annrheumdis-2019-215845

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Evaluation of SLE plasma subjected to a European study and anti-dsDNA levels for 15/174 from an international collaborative study. (A) Indirect immune fluorescence staining on HEp-2 cells using the raw material used to prepare 15/174. Photo Dr Stephan Regenass. (B) Distribution of test results for anti-dsDNA levels among the 42 European laboratories in relation to laboratory techniques used. Some laboratories performed more than one type of analysis. Levels were evaluated as negative, borderline, low, medium or high by the laboratories performing the analysis. (C) GM potency estimates (IU/mL) of 15/174 from the international collaborative study for statistically valid immunoassay results. (D) GM endpoint titres of 15/174 from the international collaborative study for the CLIFT. The numbers in the squares denote the laboratory codes. Each square represents the unweighted GM from the laboratory. ALBIA, addressable laser bead immunoassay; CLIFT, Crithidia luciliae immunofluorescent test; dsDNA, double-stranded DNA; ELISA, enzyme-linked immunosorbent assay; FEIA, fluoroenzyme immunoassay; GM, geometric mean; SLE, systemic lupus erythematosus.
Figure 1 Evaluation of SLE plasma subjected to a European study and anti-dsDNA levels for 15/174 from an international collaborative study. (A) Indirect immune fluorescence staining on HEp-2 cells using the raw material used to prepare 15/174. Photo Dr Stephan Regenass. (B) Distribution of test results for anti-dsDNA levels among the 42 European laboratories in relation to laboratory techniques used. Some laboratories performed more than one type of analysis. Levels were evaluated as negative, borderline, low, medium or high by the laboratories performing the analysis. (C) GM potency estimates (IU/mL) of 15/174 from the international collaborative study for statistically valid immunoassay results. (D) GM endpoint titres of 15/174 from the international collaborative study for the CLIFT. The numbers in the squares denote the laboratory codes. Each square represents the unweighted GM from the laboratory. ALBIA, addressable laser bead immunoassay; CLIFT, Crithidia luciliae immunofluorescent test; dsDNA, double-stranded DNA; ELISA, enzyme-linked immunosorbent assay; FEIA, fluoroenzyme immunoassay; GM, geometric mean; SLE, systemic lupus erythematosus.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 2

  1. World Health, 2006, Recommendations for the preparation, characterization and establishment of international and other biological reference standards (revised 2004), World Health Organ Tech Rep Ser, 932, 1
  2. World Health O, 2018, 1011, 48

Cited by

See all 24

Metadata

Authors
Fox, B. J., Hockley, J., Rigsby, P., Dolman, C., Meroni, P. L., & Rönnelid, J.
Affiliations
  • National Institute for Biological Standards and Control (GB)
  • IRCCS Istituto Auxologico Italiano (IT)
  • Uppsala University (SE)
Corresponding author
Fox, Bernard J
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2019-12
Volume
78
Issue
12
Pages
1677-1680
ISSN
0003-4967 (ISSN-L)
OpenAlex
W2971367708
Cited by
24
References
12
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 4 · 2021: 6 · 2020: 1 · 2019: 1
FWCI
2.27
Type
journal article
Language
en
Open access
Licence
Locations
  • Annals of the Rheumatic Diseases (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
  • HighWire Press Open Archive (submittedVersion)
Funders
Istituto Auxologico Italiano
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
  • Physical Sciences › Physics and Astronomy › Instrumentation › Scientific Measurement and Uncertainty Evaluation
Keywords
anti-dsDNA antibodies, systemic lupus erythematosus, WHO International Standard, reference reagents, anti-chromatin antibodies, anti-Ku antibodies, commutability, antibody quantification, diagnostic test standardization
MeSH terms
Antibodies, Antinuclear, DNA, Enzyme-Linked Immunosorbent Assay, Female, Humans, Lupus Erythematosus, Systemic, Prognosis, World Health Organization, Reproducibility of Results, Biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A WHO Reference Reagent for lupus (anti-dsDNA) antibodies: international collaborative study to evaluate a candidate preparation. https://app.cochat.ai/papers/10.1136/annrheumdis-2019-215845
The paper
Fox, B. J., Hockley, J., Rigsby, P., Dolman, C., Meroni, P. L., & Rönnelid, J. (2019). A WHO Reference Reagent for lupus (anti-dsDNA) antibodies: international collaborative study to evaluate a candidate preparation. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2019-215845

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.